Brief: Jubilant Pharmova Says USFDA Completes Audit Of Allergy Immunotherapy Facility, Spokane
Sept 26 (Reuters) - Jubilant Pharmova Ltd JUBA.NS :
* JUBILANT PHARMOVA - COMPLETION OF USFDA AUDIT OF ALLERGY
IMMUNOTHERAPY FACILITY, SPOKANE
* JUBILANT PHARMOVA - INSPECTION CONCLUDED WITH NO
OBSERVATIONS
* JUBILANT PHARMOVA - COMPLETION OF USFDA AUDIT OF CONTRACT
MANUFACTURING FACILITY LOCATED AT SPOKANE
Source text for Eikon: ID:nBSEgl7Z3
Further company coverage: JUBA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures